72results about How to "Treat pain" patented technology

Systems and methods are provided for applying electrical stimulation to a body by an electrode spaced from a target nerve of passage. It has been discovered that pain felt, or perceived to be felt, in a given region of the body can be treated by stimulating muscle close to a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt, such as in a case of post-amputation residual limb pain, or purportedly felt in the case of post-amputation phantom limb pain.

Medical devices, systems, and methods for pain management and other applications may apply cooling with at least one probe inserted through an exposed skin surface of skin. The cooling may remodel one or more target tissues so as to effect a desired change in composition of the target tissue and / or a change in its behavior, often to interfere with transmission of pain signals along sensory nerves. Alternative embodiments may interfere with the function of motor nerves, the function of contractile muscles, and / or some other tissue included in the contractile function chain so as to inhibit muscle contraction and thereby alleviate associated pain. In some embodiments, other sources of pain such as components of the spine (optionally including herniated disks) may be treated.

The invention relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or conditions. Additionally, the invention relates to treatment of various diseases, disorders or conditions associated with or mediated by oxidative stress since 3DG induces ROS and AGEs, which are associated with the inflammatory response caused by oxidative stress.

An apparatus and related method for controlling a load on a human ankle joint during normal gait while preserving motion. The approach is intended to treat osteoarthritis and pain of the ankle without substantially resisting an angular displacement associated with full mobility of the ankle joint.

This invention concerns a new family of phosphorus-containing macrocycles containing various phosphonate- and phosphonate-containing moieties.

The use of tapentadol for treating pain due to osteoarthritis.

The present invention is a system and method for providing an electrical stimulation signal to condition the pelvic wall muscles of a user and demonstrate to the user the proper muscle usage. The system and method also provides a system for measuring the users muscle response. The system and method also provides an entertaining interaction environment which encourages the user to perform self-initiated conditioning exercises.

Described herein are methods for using bone morphogenetic proteins (BMPs), such as OP-1 (also known as BMP-7), to treat pain caused by osteoarthritis. The methods involve administering to a patient suffering from pain caused by osteoarthritis a BMP, for example, intraarticularly by injection directly into the joint afflicted with osteoarthritis. The methods of the invention provide long-term pain relief to sufferers of osteoarthritis and can improve the functionality of the joint to which the BMP is administered.

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted aryl sulfonamides, compositions comprising these compounds, as well as methods of using these compounds or compositions in the treatment of central or peripheral nervous system disorders, particularly pain and chronic pain by blocking sodium channels associated with the onset or recurrence of the indicated conditions. The compounds, compositions and methods of the present invention are of particular use for treating neuropathic or inflammatory pain by the inhibition of ion flux through a voltage-gated sodium channel.

The present invention is concerned with the use of combinations of opioid agonists and antagonists for treating Crohn's disease.

The invention discloses an electric physical therapy hammer for treating muscular pain. The electric physical therapy hammer comprises a handle, a motor, a heat dissipation fan and a hammer body, wherein the motor and the heat dissipation fan are installed in a handle pipe hole and the hammer body is connected with the handle. The hammer body is of a hollow structure, a driving wheel, an eccentric wheel and a transmission rod are arranged in the hammer body, a rotation shaft of the motor is connected with the driving wheel through a coupler, an eccentric shaft is arranged at the end of the driving wheel, the eccentric shaft is sleeved with a rolling bearing to form the eccentric wheel, the eccentric wheel is installed in a connecting hole in the head portion of the transmission rod in a close-fit mode, and a beating head is connected to the top of the transmission rod. According to the electric physical therapy hammer for treating the muscular pain, circumferential motion of the rotation shaft of the motor is converted into up-and-down linear reciprocating motion of the beating head through the eccentric wheel, the beating head is used for conducting small-force high-frequency beating and mechanical vibration on muscles repeatedly so as to accelerate blood circulation, reduce lactic acid accumulation, break scar tissue into pieces and stimulate deep muscular tissue to accelerate injury recovery, and therefore the purse of treating the muscular pain is achieved.

Corticosteroid microparticle formulations are provided for use for treating pain, including pain caused by inflammatory diseases such as osteoarthritis or rheumatoid arthritis, and for slowing, arresting or reversing structural damage to tissues caused by an inflammatory disease, for example damage to articular and / or peri-articular tissues caused by osteoarthritis or rheumatoid arthritis. Corticosteroid microparticle formulations are administered locally as a sustained release dosage form (with or without an immediate release component) that results in efficacy accompanied by clinically insignificant or no measurable effect on endogenous cortisol production.

The present invention relates to an oral-taking traditional Chinese medicine wine comprising papaya, ligusticum chuanxiong hort, safflower and radix angelicae pubescentis, wherein 60 parts by weight of papaya, 90 parts by weight of ligusticum chuanxiong hort, 30 parts by weight of safflower, and 60 parts by weight of radix angelicae pubescentis are dried, the dried materials are crushed to achieve a particle size of 250-300 mesh, the obtained powder is loaded into a porcelain bottle, yellow wine is poured into the porcelain bottle, and soaking is performed for 7 days so as to drink the obtained wine. The oral-taking traditional Chinese medicine wine of the present invention has characteristics of red brown color and good taste, and provides treatment effects for rheumatism joint and muscle pain.

The invention discloses new application of phillyrin, phillyrin derivatives, and a phillyrin / phillygenin composition in preparation of drugs for relieving and treating pain. Tests prove that the phillyrin, phillyrin derivatives, and phillyrin / phillygenin composition have the characteristics of significant curative effect, quick effect and small toxic and side effect in treatment of pain, are a safe, efficient and stable pain treatment drug with a simple preparation process, and are suitable for industrial production and easy for popularization. The invention provides a new drug source for prevention and treatment of pain.

The invention provides a medicine for treating osteoporosis based on marine polysaccharides, which is composed of the following raw materials in parts by weight: 8-10 parts of sea cucumber glycopeptide, 6-8 parts of seaweed polysaccharide, 1.5-2.0 g of glucosamine, fish collagen 6-8 parts of protein peptide, 4-5 parts of Eucommia extract, 3-4 parts of Epimedium extract, 6-8 parts of Caulis Spatholobus extract, 3-4 parts of Rehmannia glutinosa extract, 5-7 parts of Lycium barbarum extract , this formula can eliminate joint inflammation, relieve pain, repair damaged articular cartilage and promote regeneration, and improve immunity by supplementing collagen, polypeptide, polysaccharide, calcium and other nutrients needed by bone joints. TCM theory promotes blood circulation and collaterals, nourishes liver and kidney, strengthens tendons and bones, and together achieves the fundamental purpose of treating osteoporosis.

The invention belongs to the technical field of health care and nursing of chests and particularly relates to a chest relaxing formula, a preparation method and a use method. The formula comprises oenothera biennis oil, taraxacum mongolicum oil, angelica oil, ginseng oil, peppermint oil, camellia oil, peach-kernel oil and rhizoma chuanxiong oil. The formula can be used for tightening skin, enabling the skin to be elastic, removing superfluous fat and effectively relieving physical fatigue. The formula has the overall effects of activating chest blood vessels, tightening the skin, enabling the skin to be elastic, effectively relieving chest fatigue and muscle rigidity, improving the immunity of human bodies, effectively preventing chest diseases, improving vitality of the human bodies, improving sleeping quality and relieving menstrual discomfort, is non-toxic and harmless to the human bodies, is free of side effect and has the actions of reducing weight, building bodies, enlarging breasts, improving the skin and preventing body diseases.

The present patent application relates to an ultrasonic foot massage machine, comprising a housing. A massage panel for left foot and a massage panel for right foot are arranged on the upper surface of the housing, and an ultrasonic generator and a control device for controlling the ultrasonic generator are arranged inside the housing. The ultrasonic generator is connected with a first ultrasonic transducer and a second ultrasonic transducer that emit ultrasonic of different frequencies, respectively. The first ultrasonic transducer and the second ultrasonic transducer are connected with a first group of ultrasonic emitters and a second group of ultrasonic emitters, respectively. The first group of ultrasonic emitters is divided into two equivalent subgroups of emitters which are arranged in the front sole of the foot of the left and right feet, respectively. The second group of ultrasonic emitters is also divided into two equivalent subgroups of emitters which are arranged in the rear sole of the foot of the left and right feet, respectively. The ultrasonic frequency wave directly acts upon the foot sole, which can promote the blood circulation of the whole body and relax the human body, thus treating the pain produced by problem of vein athero-obstruction.

The invention discloses the novel use of marasmius androsaceus, especially the use in preparing medicaments for improving immunity, for resisting tumor, for restoring body damage, and for treating various aches and ulcer.

The present invention provides a composition for treating pain. The composition includes a pharmaceutically acceptable analgesic and a GABAergic agent, such as gamma vinyl GABA, effective in reducing or eliminating the addictive liability of the analgesic. The invention also includes a method for reducing or eliminating the addictive

The invention discloses a paste for relieving pain and itching caused by mosquito bite. The paste comprises the following raw materials in parts by weight: 15-20 parts of eupatorium, 2-4 parts of liquorice, 5-8 parts of Chinese herbaceous peony, 0.1-0.5 part of alumen, 2-4 parts of apiary, 8-10 parts of fructus kochiae, 4-8 parts of fructus quisqualis, 1-2 parts of ligusticum wallichii, 2-3 parts of turmeric, 4-6 parts of garlic stem leaves, 1-3 parts of glycerinum, 25-50 parts of deionized water, 0.5-0.8 part of thickening agent and 50-100 parts of solvent. According to the invention, natural raw materials are selected; on the basis of scientific allocation, the required effective constituents are extracted in the manner of microwave extraction, and then effective constituents are subjected to decompression concentration, heating, pressurizing stirring, and the like; the use ratio of the effective constituents is 25% higher than that of the present manner, such as water boiling and filtering; the itching-relieving effect is specially obvious; the required time is short; the drug property is more mild; the paste is stimulation-free to a human body; the pregnant women, infants or low-immunity people all can use the paste; the paste is free from toxic or side effect.

A portable moxibustion therapy device includes a main body 20, having a top opening 21, a sidewall 22 and a bottom 23, and the sidewall 22 comprises a plurality of holes 24 on the sidewall 22 of the main body 20; a cover 30 for opening and closing the top opening 21 of the main body 20; a moxa container 40 which is substantially cylindrical and made of yellow soil in the main body 20; a cylindrical support 50 made of yellow soil placed the moxa container 40 blow in the main body 20; and a gauze 60 located between the moxa container 40 and the cylindrical support 50 in the main body 20. The portable moxibustion therapy device includes a plurality of holes to supply air or oxygen to the moxa 90.

The present invention provides an antibody or antibody fragment thereof for a targeted cytomembrane voltage-gated sodium channel α subunit Nav1.9. The specific binding target is a S3-4 ring of a voltage sensor paddle of a domain II of the voltage-gated sodium channel α subunit. The antibody or antibody fragment thereof is able to inactivate a voltage sensor valve, to make sodium ions unable to enter nerve cells normally, thereby achieving the effect of treating and relieving pains.

Ankle distraction or load bypassing devices include a shoe or shoe insert that securely holds a patient's foot, and a cuff that securely holds the patient's lower leg. A load bypassing device can transmit force between the cuff and the shoe or shoe insert bypassing a portion of the load around the joint. A distraction force generating mechanism between the cuff and the shoe or shoe insert can distract the patient's ankle, while permitting the ankle to flex at a joint which joins together the cuff and the shoe.